{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:30:37Z","timestamp":1791495037044,"version":"4.3.4"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:00:00Z","timestamp":1530489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009714","name":"Children's Cardiomyopathy Foundation","doi-asserted-by":"publisher","award":["2016"],"award-info":[{"award-number":["2016"]}],"id":[{"id":"10.13039\/100009714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12012-018-9462-2","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T06:35:12Z","timestamp":1530513312000},"page":"493-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders"],"prefix":"10.1007","volume":"18","author":[{"given":"Robert J.","family":"Henning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond D.","family":"Harbison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"issue":"6","key":"9462_CR1","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.mam.2013.05.002","volume":"34","author":"L Vir\u00e1g","year":"2013","unstructured":"Vir\u00e1g, L. (2013). 50 Years of poly(ADP-ribosyl)ation. Molecular Aspects of Medicine, 34(6), 1043\u20131045. https:\/\/doi.org\/10.1016\/j.mam.2013.05.002 .","journal-title":"Molecular Aspects of Medicine"},{"key":"9462_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/med.21300","volume":"34","author":"S Xu","year":"2014","unstructured":"Xu, S., Bai, P., Little, P., & Liu, P. (2014). Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: From molecular mechanisms to therapeutic implications. Medicinal Research Reviews, 34, 644\u2013675. https:\/\/doi.org\/10.1002\/med.21300 .","journal-title":"Medicinal Research Reviews"},{"key":"9462_CR3","first-page":"80","volume-title":"From DNA damage and stress signaling to cell death: Poly ADP-ribosylation reactions","author":"A Burkle","year":"2000","unstructured":"Burkle, A., Schreiber, V., Dantzer, F., & Oliver, F. (2000). Biological significance of poly(ADP-ribosylation) reactions: Molecular and genetic approaches. In G. de Murcia & S. Shall (Eds.), From DNA damage and stress signaling to cell death: Poly ADP-ribosylation reactions (pp. 80\u2013124). Oxford: Oxford University Press."},{"key":"9462_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1196\/annals.1427.014","volume":"1147","author":"SA Andrabi","year":"2008","unstructured":"Andrabi, S. A., Dawson, T. M., & Dawson, V. L. (2008). Mitochondrial and nuclear cross talk in cell death: Parthanatos. Annals of the New York Academy of Sciences, 1147, 233\u2013241.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"8","key":"9462_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/bies.20085","volume":"26","author":"JC Am\u00e9","year":"2004","unstructured":"Am\u00e9, J. C., Spenlehauer, C., & de Murcia, G. (2004). The PARP superfamily. BioEssays, 26(8), 882\u2013893.","journal-title":"BioEssays"},{"key":"9462_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.03.018","author":"M Vos De","year":"2012","unstructured":"De Vos, M., Schreiber, V., & Dantzer, F. (2012). The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art. Biochemical Pharmacology. https:\/\/doi.org\/10.1016\/j.bcp.2012.03.018 .","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"9462_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2010.06.017","volume":"39","author":"R Krishnakumar","year":"2010","unstructured":"Krishnakumar, R., & Kraus, W. L. (2010). The PARP side of the nucleus: Molecular actions, physiological outcomes, and clinical targets. Molecular Cell, 39(1), 8\u201324.","journal-title":"Molecular Cell"},{"issue":"6","key":"9462_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.mam.2013.01.005","volume":"34","author":"WL Kraus","year":"2013","unstructured":"Kraus, W. L., & Hottiger, M. O. (2013). PARP-1 and gene regulation: Progress and puzzles. Molecular Aspects of Medicine, 34(6), 1109\u20131123.","journal-title":"Molecular Aspects of Medicine"},{"issue":"5","key":"9462_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1101\/gad.183509.111","volume":"26","author":"X Luo","year":"2012","unstructured":"Luo, X., & Kraus, W. L. (2012). On PAR with PARP: Cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes & Development, 26(5), 417\u2013432.","journal-title":"Genes & Development"},{"issue":"7\u20138","key":"9462_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00018-004-4503-3","volume":"62","author":"J Diefenbach","year":"2005","unstructured":"Diefenbach, J., & B\u00fcrkle, A. (2005). Introduction to poly(ADP-ribose) metabolism. Cellular and Molecular Life Sciences, 62(7\u20138), 721\u2013730.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"Pt 2","key":"9462_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/0264-6021:3420249","volume":"342","author":"D D\u2019Amours","year":"1999","unstructured":"D\u2019Amours, D., Desnoyers, S., D\u2019Silva, I., & Poirier, G. G. (1999). Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochemical Journal, 342(Pt 2), 249\u2013268.","journal-title":"Biochemical Journal"},{"issue":"16","key":"9462_CR12","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1093\/nar\/gks486","volume":"40","author":"JP Gagne","year":"2012","unstructured":"Gagne, J. P., Pic, E., Isabelle, M., Krietsch, J., Ethier, C., Paquet, E., et al. (2012). Quantitative proteomics profiling of the poly(ADP-ribose)-related response to genotoxic stress. Nucleic Acids Research, 40(16), 7788\u20137805.","journal-title":"Nucleic Acids Research"},{"issue":"1\u20132","key":"9462_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0300-483X(03)00287-7","volume":"193","author":"M Christmann","year":"2003","unstructured":"Christmann, M., Tomicic, M. T., Roos, W. P., & Kaina, B. (2003). Mechanisms of human DNA repair: An update. Toxicology, 193(1\u20132), 3\u201334.","journal-title":"Toxicology"},{"issue":"1","key":"9462_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2005.02.016","volume":"52","author":"S Cuzzocrea","year":"2005","unstructured":"Cuzzocrea, S. (2005). Shock, inflammation and PARP. Pharmacological Research, 52(1), 72\u201382.","journal-title":"Pharmacological Research"},{"issue":"6","key":"9462_CR15","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.mam.2013.01.007","volume":"34","author":"L Vir\u00e1g","year":"2013","unstructured":"Vir\u00e1g, L., Robaszkiewicz, A., Rodriguez-Vargas, J. M., & Oliver, F. J. (2013). Poly(ADP-ribose) signaling in cell death. Molecular Aspects of Medicine, 34(6), 1153\u20131167.","journal-title":"Molecular Aspects of Medicine"},{"issue":"3","key":"9462_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","volume":"25","author":"P Pacher","year":"2007","unstructured":"Pacher, P., & Szab\u00f3, C. (2007). Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: The therapeutic potential of PARP inhibitors. Cardiovascular Drug Reviews, 25(3), 235\u2013260.","journal-title":"Cardiovascular Drug Reviews"},{"issue":"5579","key":"9462_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1126\/science.1072221","volume":"297","author":"SW Yu","year":"2002","unstructured":"Yu, S. W., Wang, H., Poitras, M., Coombs, C., Bowers, W. J., Federoff, H. J., et al. (2002). Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 297(5579), 259\u2013263.","journal-title":"Science"},{"issue":"48","key":"9462_CR18","doi-asserted-by":"publisher","first-page":"18314","DOI":"10.1073\/pnas.0606528103","volume":"103","author":"SW Yu","year":"2006","unstructured":"Yu, S. W., Andrabi, S., Wang, H., Kim, N. S., Poirier, G. G., Dawson, T. M., et al. (2006). Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proceedings of the National Academy of Sciences of the United States of America, 103(48), 18314\u201318319.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"9462_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1023\/B:JOBB.0000041755.22613.8d","volume":"36","author":"VL Dawson","year":"2004","unstructured":"Dawson, V. L., & Dawson, T. M. (2004). Deadly conversations: Nuclear-mitochondrial cross-talk. Journal of Bioenergetics and Biomembranes, 36(4), 287\u2013294.","journal-title":"Journal of Bioenergetics and Biomembranes"},{"issue":"4","key":"9462_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cardiores.2004.04.018","volume":"63","author":"M Chen","year":"2004","unstructured":"Chen, M., Zsengell\u00e9r, Z., Xiao, C. Y., & Szab\u00f3, C. (2004). Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: Potential role of poly(ADP-ribose) polymerase-1. Cardiovascular Research, 63(4), 682\u2013688.","journal-title":"Cardiovascular Research"},{"issue":"49","key":"9462_CR21","doi-asserted-by":"publisher","first-page":"40450","DOI":"10.1074\/jbc.M507553200","volume":"280","author":"PO Hassa","year":"2005","unstructured":"Hassa, P. O., Haenni, S. S., Buerki, C., Meier, N. I., Lane, W. S., Owen, H., et al. (2005). Acetylation of poly(ADP-ribose) polymerase-1 by p300\/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. Journal of Biological Chemistry, 280(49), 40450\u201340464.","journal-title":"Journal of Biological Chemistry"},{"issue":"16","key":"9462_CR22","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1093\/emboj\/18.16.4446","volume":"18","author":"FJ Oliver","year":"1999","unstructured":"Oliver, F. J., M\u00e9nissier-de Murcia, J., Nacci, C., Decker, P., Andriantsitohaina, R., Muller, S., et al. (1999). Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO Journal, 18(16), 4446\u20134454.","journal-title":"EMBO Journal"},{"issue":"5","key":"9462_CR23","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1073\/pnas.052712399","volume":"99","author":"HC Ha","year":"2002","unstructured":"Ha, H. C., Hester, L. D., & Snyder, S. H. (2002). Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proceedings of the National Academy of Sciences of the United States of America, 99(5), 3270\u20133275.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Pt 3","key":"9462_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1042\/bj3460641","volume":"346","author":"M Kameoka","year":"2000","unstructured":"Kameoka, M., Ota, K., Tetsuka, T., Tanaka, Y., Itaya, A., Okamoto, T., et al. (2000). Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. Biochemical Journal, 346(Pt 3), 641\u2013649.","journal-title":"Biochemical Journal"},{"issue":"1","key":"9462_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/cvr\/cvm110","volume":"78","author":"T Lukowicz von","year":"2008","unstructured":"von Lukowicz, T., Hassa, P. O., Lohmann, C., Boren, J., Braunersreuther, V., Mach, F., et al. (2008). PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovascular Research, 78(1), 158\u2013166.","journal-title":"Cardiovascular Research"},{"key":"9462_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2013.01.006","author":"NJ Curtin","year":"2013","unstructured":"Curtin, N. J., & Szabo, C. (2013). Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond. Molecular Aspects of Medicine. https:\/\/doi.org\/10.1016\/j.mam.2013.01.006 .","journal-title":"Molecular Aspects of Medicine"},{"issue":"9","key":"9462_CR27","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.freeradbiomed.2011.08.006","volume":"51","author":"P Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay, P., Horv\u00e1th, B., Kechrid, M., Tanchian, G., Rajesh, M., Naura, A. S., et al. (2011). Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury. Free Radical Biology and Medicine, 51(9), 1774\u20131788.","journal-title":"Free Radical Biology and Medicine"},{"issue":"4","key":"9462_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2567.2004.01991.x","volume":"113","author":"B Zingarelli","year":"2004","unstructured":"Zingarelli, B., Hake, P. W., Burroughs, T. J., Piraino, G., O\u2019Connor, M., & Denenberg, A. (2004). Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis. Immunology, 113(4), 509\u2013517.","journal-title":"Immunology"},{"key":"9462_CR29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00953.2003","author":"B Zingarelli","year":"2004","unstructured":"Zingarelli, B., Hake, P. W., O\u2019Connor, M., Denenberg, A., Wong, H. R., Kong, S., et al. (2004). Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: Role of poly(ADP-ribose) polymerase-1. American Journal of Physiology Heart and Circulatory Physiology. https:\/\/doi.org\/10.1152\/ajpheart.00953.2003 .","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"9462_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600244","author":"F Yeung","year":"2004","unstructured":"Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., et al. (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO Journal. https:\/\/doi.org\/10.1038\/sj.emboj.7600244 .","journal-title":"EMBO Journal"},{"key":"9462_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.06.007","author":"A Kauppinen","year":"2013","unstructured":"Kauppinen, A., Suuronen, T., Ojala, J., Kaarniranta, K., & Salminen, A. (2013). Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders. Cellular Signalling. https:\/\/doi.org\/10.1016\/j.cellsig.2013.06.007 .","journal-title":"Cellular Signalling"},{"key":"9462_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/bies.10317","author":"J Zhang","year":"2003","unstructured":"Zhang, J. (2003). Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? BioEssays. https:\/\/doi.org\/10.1002\/bies.10317 .","journal-title":"BioEssays"},{"key":"9462_CR33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M506162200","author":"JB Pillai","year":"2005","unstructured":"Pillai, J. B., Isbatan, A., Imai, S., & Gupta, M. P. (2005). Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. Journal of Biological Chemistry. https:\/\/doi.org\/10.1074\/jbc.M506162200 .","journal-title":"Journal of Biological Chemistry"},{"key":"9462_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.06.007","author":"JB Pillai","year":"2005","unstructured":"Pillai, J. B., Russell, H. M., Raman, J., Jeevanandam, V., & Gupta, M. P. (2005). Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure. American Journal of Physiology Heart and Circulatory Physiology. https:\/\/doi.org\/10.1016\/j.cellsig.2013.06.007 .","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"9462_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1124\/pr.54.3.375","volume":"54","author":"L Vir\u00e1g","year":"2002","unstructured":"Vir\u00e1g, L., & Szab\u00f3, C. (2002). The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacological Reviews, 54, 375\u2013429.","journal-title":"Pharmacological Reviews"},{"key":"9462_CR36","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3760\/cma.j.issn.0366-6999.20121234","volume":"126","author":"Z Song","year":"2013","unstructured":"Song, Z., Chen, D., Du, B., & Ji, X. (2013). Poly (ADP-ribose) polymerase inhibitor reduces heart ischaemia\/reperfusion injury via inflammation and Akt signaling in rats. Chinese Medical Journal, 126, 1913\u20131917.","journal-title":"Chinese Medical Journal"},{"key":"9462_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1527-5299.2007.06595.x","volume":"13","author":"GW Booz","year":"2007","unstructured":"Booz, G. W. (2007). PARP inhibitors and heart failure\u2013translational medicine caught in the act. Congestive Heart Failure, 13, 105\u2013112.","journal-title":"Congestive Heart Failure"},{"key":"9462_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2121","author":"E Wahlberg","year":"2012","unstructured":"Wahlberg, E., Karlberg, T., Kouznetsova, E., Markova, N., Macchiarulo, A., Thorsell, A. G., et al. (2012). Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nature Biotechnology. https:\/\/doi.org\/10.1038\/nbt.2121 .","journal-title":"Nature Biotechnology"},{"key":"9462_CR39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/0014-4827(86)90550-1","volume":"165","author":"KM Milam","year":"1986","unstructured":"Milam, K. M., Thomas, G. H., & Cleaver, J. E. (1986). Disturbances in DNA precursor metabolism associated with exposure to an inhibitor of poly(ADP-ribose) synthetase. Experimental Cell Research, 165, 260\u2013268.","journal-title":"Experimental Cell Research"},{"key":"9462_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-008-6146-3","author":"X Yu","year":"2009","unstructured":"Yu, X., Cheng, X., Xie, J. J., Liao, M. Y., Yao, R., Chen, Y., et al. (2009). Poly (ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by hyper-homocysteinemia in rats. Cardiovascular Drugs and Therapy. https:\/\/doi.org\/10.1007\/s10557-008-6146-3 .","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"9462_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0008-6363(97)00137-5","volume":"36","author":"B Zingarelli","year":"1997","unstructured":"Zingarelli, B., Cuzzocrea, S., Zsengell\u00e9r, Z., Salzman, A. L., & Szab\u00f3, C. (1997). Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovascular Research, 36, 205\u2013215.","journal-title":"Cardiovascular Research"},{"key":"9462_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvn018","author":"CP Hans","year":"2008","unstructured":"Hans, C. P., Zerfaoui, M., Naura, A. S., Catling, A., & Boulares, A. H. (2008). Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability. Cardiovascular Research. https:\/\/doi.org\/10.1093\/cvr\/cvn018 .","journal-title":"Cardiovascular Research"},{"key":"9462_CR43","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.145938","author":"CP Hans","year":"2009","unstructured":"Hans, C. P., Zerfaoui, M., Naura, A. S., Troxclair, D., Strong, J. P., Matrougui, K., et al. (2009). Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: Effects on inflammatory markers and lipid content. Journal of Pharmacology and Experimental Therapeutics. https:\/\/doi.org\/10.1124\/jpet.108.145938 .","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9462_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2119\/2004-00001.Szabo","volume":"10","author":"C Szab\u00f3","year":"2004","unstructured":"Szab\u00f3, C., Pacher, P., Zsengell\u00e9r, Z., Vaslin, A., Komj\u00e1ti, K., Benk\u00f6, R., et al. (2004). Angiotensin II-mediated endothelial dysfunction: Role of poly(ADP-ribose) polymerase activation. Molecular Medicine, 10, 28\u201335.","journal-title":"Molecular Medicine"},{"key":"9462_CR45","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/hh2001.097797","volume":"89","author":"FG Soriano","year":"2001","unstructured":"Soriano, F. G., Pacher, P., Mabley, J., Liaudet, L., & Szab\u00f3, C. (2001). Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circulation Research, 89, 684\u2013691.","journal-title":"Circulation Research"},{"key":"9462_CR46","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00162.2004","author":"C Zhang","year":"2004","unstructured":"Zhang, C., Yang, J., & Jennings, L. K. (2004). Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery. American Journal of Physiology Heart and Circulatory Physiology. https:\/\/doi.org\/10.1152\/ajpheart.00162.2004 .","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"9462_CR47","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.190140","author":"SK Choi","year":"2012","unstructured":"Choi, S. K., Gal\u00e1n, M., Kassan, M., Partyka, M., Trebak, M., & Matrougui, K. (2012). Poly(ADP-ribose)polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus. Hypertension. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.190140 .","journal-title":"Hypertension"},{"key":"9462_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00183.x","author":"ZF Song","year":"2008","unstructured":"Song, Z. F., Ji, X. P., Li, X. X., Wang, S. J., Wang, S. H., & Zhang, Y. (2008). Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia\/reperfusion injury via suppressing JNK-mediated AIF translocation. Journal of Cellular and Molecular Medicine. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00183.x .","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9462_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-008-0230-1","author":"DA Morrow","year":"2009","unstructured":"Morrow, D. A., Brickman, C. M., Murphy, S. A., Baran, K., Krakover, R., Dauerman, H., et al. (2009). A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Results of the TIMI 37 trial. Journal of Thrombosis and Thrombolysis. https:\/\/doi.org\/10.1007\/s11239-008-0230-1 .","journal-title":"Journal of Thrombosis and Thrombolysis"},{"key":"9462_CR50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0006-291X(72)80169-4","volume":"46","author":"K Ueda","year":"1972","unstructured":"Ueda, K., Oka, J., Naruniya, S., Miyakawa, N., & Hayaishi, O. (1972). Poly ADP-ribose glycohydrolase from rat liver nuclei, a novel enzyme degrading the polymer. Biochemical and Biophysical Research Communications, 46, 516\u2013523.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9462_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/2047-783X-16-8-367","volume":"16","author":"C Erbel","year":"2011","unstructured":"Erbel, C., Achenbach, J., Akhavanpoor, M., Dengler, T. J., Lasitschka, F., Gleissner, C. A., et al. (2011). PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels. European Journal of Medical Research, 16, 367\u2013374.","journal-title":"European Journal of Medical Research"},{"key":"9462_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2005.11.021","author":"CJ Beller","year":"2006","unstructured":"Beller, C. J., Radovits, T., Kosse, J., Ger\u00f6, D., Szab\u00f3, C., & Szab\u00f3, G. (2006). Activation of the peroxynitrite-poly(adenosine diphosphate-ribose) polymerase pathway during neointima proliferation: A new target to prevent restenosis after endarterectomy. Journal of Vascular Surgery. https:\/\/doi.org\/10.1016\/j.jvs.2005.11.021 .","journal-title":"Journal of Vascular Surgery"},{"key":"9462_CR53","first-page":"247","volume":"62","author":"M Pawlowska","year":"2011","unstructured":"Pawlowska, M., Gajda, M., Pyka-Fosciak, G., Toton-Zuranska, J., Niepsuj, A., Kus, K., et al. (2011). The effect of doxycycline on atherogenesis in apoE-knockout mice. Journal of Physiology and Pharmacology, 62, 247\u2013250.","journal-title":"Journal of Physiology and Pharmacology"},{"key":"9462_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64929-2","author":"MP Bendeck","year":"2002","unstructured":"Bendeck, M. P., Conte, M., Zhang, M., Nili, N., Strauss, B. H., & Farwell, S. M. (2002). Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. American Journal of Pathology. https:\/\/doi.org\/10.1016\/S0002-9440(10)64929-2 .","journal-title":"American Journal of Pathology"},{"key":"9462_CR55","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000121571.78696.dc","author":"DL Brown","year":"2004","unstructured":"Brown, D. L., Desai, K. K., Vakili, B. A., Nouneh, C., Lee, H. M., & Golub, L. M. (2004). Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arteriosclerosis, Thrombosis, and Vascular Biology. https:\/\/doi.org\/10.1161\/01.ATV.0000121571.78696.dc .","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9462_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2010.03.007","author":"CP Hans","year":"2011","unstructured":"Hans, C. P., Feng, Y., Naura, A. S., Troxclair, D., Zerfaoui, M., Siddiqui, D., et al. (2011). Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy. Cardiovascular Pathology. https:\/\/doi.org\/10.1016\/j.carpath.2010.03.007 .","journal-title":"Cardiovascular Pathology"},{"key":"9462_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007430","author":"CP Hans","year":"2009","unstructured":"Hans, C. P., Feng, Y., Naura, A. S., Zerfaoui, M., Rezk, B. M., Xia, H., et al. (2009). Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: Effects on eNOS and oxidative stress. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0007430 .","journal-title":"PLoS ONE"},{"key":"9462_CR58","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/pr.54.4.619","volume":"54","author":"IV Turko","year":"2002","unstructured":"Turko, I. V., & Murad, F. (2002). Protein nitration in cardiovascular diseases. Pharmacological Reviews, 54, 619\u2013634.","journal-title":"Pharmacological Reviews"},{"key":"9462_CR59","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby, P., Ridker, P. M., & Maseri, A. (2002). Inflammation and atherosclerosis. Circulation, 105, 1135\u20131143.","journal-title":"Circulation"},{"key":"9462_CR60","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00029.2006","author":"P Pacher","year":"2007","unstructured":"Pacher, P., Beckman, J. S., & Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiological Reviews. https:\/\/doi.org\/10.1152\/physrev.00029.2006 .","journal-title":"Physiological Reviews"},{"key":"9462_CR61","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.106.668756","author":"K Oumouna-Benachour","year":"2007","unstructured":"Oumouna-Benachour, K., Hans, C. P., Suzuki, Y., Naura, A., Datta, R., Belmadani, S., et al. (2007). Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: Effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation. https:\/\/doi.org\/10.1161\/circulationaha.106.668756 .","journal-title":"Circulation"},{"key":"9462_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/nature01323","author":"P Libby","year":"2002","unstructured":"Libby, P. (2002). Inflammation in atherosclerosis. Nature. https:\/\/doi.org\/10.1038\/nature01323 .","journal-title":"Nature"},{"key":"9462_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2008.08.005","author":"I Perrotta","year":"2009","unstructured":"Perrotta, I., Brunelli, E., Sciangula, A., Zuccal\u00e0, V., Donato, G., Tripepi, S., et al. (2009). Inducible and endothelial nitric oxide synthase expression in human atherogenesis: An immunohistochemical and ultrastructural study. Cardiovascular Pathology. https:\/\/doi.org\/10.1016\/j.carpath.2008.08.005 .","journal-title":"Cardiovascular Pathology"},{"issue":"3","key":"9462_CR64","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.neurobiolaging.2004.06.018","volume":"26","author":"YX Wang","year":"2005","unstructured":"Wang, Y. X. (2005). Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice. Neurobiology of Aging, 26(3), 309\u2013316.","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"9462_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1254\/jphs.FMJ04006X6","volume":"96","author":"S Kawashima","year":"2004","unstructured":"Kawashima, S. (2004). Malfunction of vascular control in lifestyle-related diseases: Endothelial nitric oxide (NO) synthase\/NO system in atherosclerosis. Journal of Pharmacological Sciences, 96(4), 411\u2013419.","journal-title":"Journal of Pharmacological Sciences"},{"issue":"8","key":"9462_CR66","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/01.CIR.0000026393.47805.21","volume":"106","author":"W Martinet","year":"2002","unstructured":"Martinet, W., Knaapen, M. W., De Meyer, G. R., Herman, A. G., & Kockx, M. M. (2002). Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation, 106(8), 927\u2013932.","journal-title":"Circulation"},{"issue":"9","key":"9462_CR67","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","volume":"59","author":"PO Hassa","year":"2002","unstructured":"Hassa, P. O., & Hottiger, M. O. (2002). The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cellular and Molecular Life Sciences, 59(9), 1534\u20131553.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2","key":"9462_CR68","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/nar\/gkh239","volume":"32","author":"A Carrillo","year":"2004","unstructured":"Carrillo, A., Monreal, Y., Ram\u00edrez, P., Marin, L., Parrilla, P., Oliver, F. J., et al. (2004). Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. Nucleic Acids Research, 32(2), 757\u2013766.","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"9462_CR69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/01.RES.83.1.85","volume":"83","author":"B Zingarelli","year":"1998","unstructured":"Zingarelli, B., Salzman, A. L., & Szab\u00f3, C. (1998). Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia\/reperfusion injury. Circulation Research, 83(1), 85\u201394.","journal-title":"Circulation Research"},{"issue":"5","key":"9462_CR70","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5551\/jat.1586","volume":"16","author":"JJ Xie","year":"2009","unstructured":"Xie, J. J., Yu, X., Liao, Y. H., Chen, J., Yao, R., Chen, Y., et al. (2009). Poly(ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE\u2212\/\u2212 mice with hyperhomocysteinemia. Journal of Atherosclerosis and Thrombosis, 16(5), 641\u2013653.","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"key":"9462_CR71","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12685","author":"SJ Wei","year":"2017","unstructured":"Wei, S. J., Cheng, L., Liang, E. S., Wang, Q., Zhou, S. N., Xu, H., et al. (2017). Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II. Clinical and Experimental Pharmacology and Physiology. https:\/\/doi.org\/10.1111\/1440-1681.12685 .","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"10","key":"9462_CR72","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.lfs.2004.04.007","volume":"75","author":"R Benk\u00f6","year":"2004","unstructured":"Benk\u00f6, R., Pacher, P., Vaslin, A., Kollai, M., & Szab\u00f3, C. (2004). Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase. Life Sciences, 75(10), 1255\u20131261.","journal-title":"Life Sciences"},{"key":"9462_CR73","doi-asserted-by":"publisher","DOI":"10.1177\/2048872615570770","author":"L Roeck De","year":"2016","unstructured":"De Roeck, L., Vandamme, S., Everaert, B. R., Hoymans, V., Haine, S., Vandendriessche, T., et al. (2016). Adiponectin and ischemia-reperfusion injury in ST segment elevation myocardial infarction. European Heart Journal: Acute Cardiovascular Care. https:\/\/doi.org\/10.1177\/2048872615570770 .","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"issue":"3","key":"9462_CR74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2174\/1570161054368607","volume":"3","author":"Z Ungv\u00e1ri","year":"2005","unstructured":"Ungv\u00e1ri, Z., Gupte, S. A., Recchia, F. A., B\u00e1tkai, S., & Pacher, P. (2005). Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Current Vascular Pharmacology, 3(3), 221\u2013229.","journal-title":"Current Vascular Pharmacology"},{"key":"9462_CR75","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2011.642373","author":"K Yamazaki","year":"2013","unstructured":"Yamazaki, K., Tanaka, S., Sakata, R., Miwa, S., Oriyanhan, W., Takaba, K., et al. (2013). Protective effect of cardioplegia with poly (ADP-ribose) polymerase-1 inhibitor against myocardial ischemia-reperfusion injury: In vitro study of isolated rat heart model. Journal of Enzyme Inhibition and Medicinal Chemistry. https:\/\/doi.org\/10.3109\/14756366.2011.642373 .","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"9462_CR76","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000000061","author":"M Wang","year":"2016","unstructured":"Wang, M., Hu, B., Zhang, Y. L., Shen, E., & Pan, X. Q. (2016). Effects of 3-aminobenzamide on ventricular function in infarct heart assessed by quantitative tissue velocity imaging. Journal of Cardiovascular Medicine (Hagerstown). https:\/\/doi.org\/10.2459\/JCM.0000000000000061 .","journal-title":"Journal of Cardiovascular Medicine (Hagerstown)"},{"key":"9462_CR77","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e3181c4fb08","author":"JP Roesner","year":"2010","unstructured":"Roesner, J. P., Mersmann, J., Bergt, S., Bohnenberg, K., Barthuber, C., Szabo, C., et al. (2010). Therapeutic injection of PARP inhibitor INO-1001 preserves cardiac function in porcine myocardial ischemia and reperfusion without reducing infarct size. Shock. https:\/\/doi.org\/10.1097\/SHK.0b013e3181c4fb08 .","journal-title":"Shock"},{"issue":"2","key":"9462_CR78","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0003-4975(01)03329-X","volume":"73","author":"R Faro","year":"2002","unstructured":"Faro, R., Toyoda, Y., McCully, J. D., Jagtap, P., Szabo, E., Virag, L., et al. (2002). Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor. Annals of Thoracic Surgery, 73(2), 575\u2013581.","journal-title":"Annals of Thoracic Surgery"},{"issue":"6","key":"9462_CR79","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1124\/mol.59.6.1497","volume":"59","author":"R Halmosi","year":"2001","unstructured":"Halmosi, R., Berente, Z., Osz, E., Toth, K., Literati-Nagy, P., & Sumegi, B. (2001). Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Molecular Pharmacology, 59(6), 1497\u20131505.","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"9462_CR80","doi-asserted-by":"publisher","first-page":"H714","DOI":"10.1152\/ajpheart.00823.2005","volume":"291","author":"HZ Zhou","year":"2006","unstructured":"Zhou, H. Z., Swanson, R. A., Simonis, U., Ma, X., Cecchini, G., & Gray, M. O. (2006). Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts. American Journal of Physiology Heart and Circulatory Physiology, 291(2), H714\u2013H723.","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"issue":"24","key":"9462_CR81","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1007\/s00018-006-6345-7","volume":"63","author":"C Fiorillo","year":"2006","unstructured":"Fiorillo, C., Ponziani, V., Giannini, L., Cecchi, C., Celli, A., Nassi, N., et al. (2006). Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts. Cellular and Molecular Life Sciences, 63(24), 3061\u20133071.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"3","key":"9462_CR82","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.athoracsur.2005.02.035","volume":"80","author":"AS Farivar","year":"2005","unstructured":"Farivar, A. S., McCourtie, A. S., MacKinnon-Patterson, B. C., Woolley, S. M., Barnes, A. D., Chen, M., et al. (2005). Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival. Annals of Thoracic Surgery, 80(3), 950\u2013956.","journal-title":"Annals of Thoracic Surgery"},{"issue":"3","key":"9462_CR83","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1570161054368599","volume":"3","author":"G Szab\u00f3","year":"2005","unstructured":"Szab\u00f3, G., & B\u00e4hrle, S. (2005). Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury. Current Vascular Pharmacology, 3(3), 215\u2013220.","journal-title":"Current Vascular Pharmacology"},{"key":"9462_CR84","first-page":"333","volume-title":"Critical care cardiology","author":"RJ Henning","year":"1989","unstructured":"Henning, R. J. (1989). Acute myocardial infarction. In R. J. Henning & A. Grenvik (Eds.), Critical care cardiology (pp. 333\u2013400). New York: Churchill Livingstone."},{"key":"9462_CR85","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-016-9394-7","author":"BU Islam","year":"2017","unstructured":"Islam, B. U., Habib, S., Ali, S. A., & Ali, N. (2017). Role of peroxynitrite-induced activation of poly(ADP-ribose) polymerase (PARP) in circulatory shock and related pathological conditions. Cardiovascular Toxicology. https:\/\/doi.org\/10.1007\/s12012-016-9394-7 .","journal-title":"Cardiovascular Toxicology"},{"issue":"7\u20138","key":"9462_CR86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2119\/2006-00043.Molnar","volume":"12","author":"A Moln\u00e1r","year":"2006","unstructured":"Moln\u00e1r, A., T\u00f3th, A., Bagi, Z., Papp, Z., Edes, I., Vaszily, M., et al. (2006). Activation of the poly(ADP-ribose) polymerase pathway in human heart failure. Molecular Medicine, 12(7\u20138), 143\u2013152.","journal-title":"Molecular Medicine"},{"issue":"6","key":"9462_CR87","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1161\/hc3201.092284","volume":"104","author":"Q Feng","year":"2001","unstructured":"Feng, Q., Lu, X., Jones, D. L., Shen, J., & Arnold, J. M. (2001). Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation, 104(6), 700\u2013704.","journal-title":"Circulation"},{"issue":"4","key":"9462_CR88","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0008-6363(00)00307-2","volume":"49","author":"MJ Mihm","year":"2001","unstructured":"Mihm, M. J., Coyle, C. M., Schanbacher, B. L., Weinstein, D. M., & Bauer, J. A. (2001). Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovascular Research, 49(4), 798\u2013807.","journal-title":"Cardiovascular Research"},{"key":"9462_CR89","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.069658","author":"P Pacher","year":"2004","unstructured":"Pacher, P., Vaslin, A., Benko, R., Mabley, J. G., Liaudet, L., Hask\u00f3, G., et al. (2004). A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. Journal of Pharmacology and Experimental Therapeutics. https:\/\/doi.org\/10.1124\/jpet.104.069658 .","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"9462_CR90","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1124\/jpet.104.077164","volume":"312","author":"CY Xiao","year":"2005","unstructured":"Xiao, C. Y., Chen, M., Zsengell\u00e9r, Z., Li, H., Kiss, L., Kollai, M., et al. (2005). Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure. Journal of Pharmacology and Experimental Therapeutics, 312(3), 891\u2013898.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"9462_CR91","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0022-3565(24)39082-2","volume":"294","author":"DM Weinstein","year":"2000","unstructured":"Weinstein, D. M., Mihm, M. J., & Bauer, J. A. (2000). Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. Journal of Pharmacology and Experimental Therapeutics, 294(1), 396\u2013401.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"9462_CR92","first-page":"505","volume":"11","author":"P Bai","year":"2004","unstructured":"Bai, P., Mabley, J. G., Liaudet, L., Vir\u00e1g, L., Szab\u00f3, C., & Pacher, P. (2004). Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity. Oncology Reports, 11(2), 505\u2013508.","journal-title":"Oncology Reports"},{"issue":"5","key":"9462_CR93","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.bcp.2004.11.023","volume":"69","author":"O Szenczi","year":"2005","unstructured":"Szenczi, O., Kenecsei, P., Holthuijsen, M. F., van Riel, N. A., van der Vusse, G. J., Pacher, P., et al. (2005). Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochemical Pharmacology, 69(5), 725\u2013732.","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"9462_CR94","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2337\/diabetes.51.2.514","volume":"51","author":"P Pacher","year":"2002","unstructured":"Pacher, P., Liaudet, L., Soriano, F. G., Mabley, J. G., Szab\u00f3, E., & Szab\u00f3, C. (2002). The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes, 51(2), 514\u2013521.","journal-title":"Diabetes"},{"issue":"5","key":"9462_CR95","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s003950200050","volume":"97","author":"CS Baker","year":"2002","unstructured":"Baker, C. S., Dutka, D. P., Pagano, D., Rimoldi, O., Pitt, M., Hall, R. J., et al. (2002). Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium. Basic Research in Cardiology, 97(5), 409\u2013415.","journal-title":"Basic Research in Cardiology"},{"issue":"14","key":"9462_CR96","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.1073\/pnas.96.14.8144","volume":"96","author":"J Narula","year":"1999","unstructured":"Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F. D., et al. (1999). Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America, 96(14), 8144\u20138149.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"9462_CR97","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1527-5299.2002.00717.x","volume":"8","author":"D Sorescu","year":"2002","unstructured":"Sorescu, D., & Griendling, K. K. (2002). Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congestive Heart Failure, 8(3), 132\u2013140.","journal-title":"Congestive Heart Failure"},{"issue":"14","key":"9462_CR98","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2174\/1381612043384718","volume":"10","author":"R Ferrari","year":"2004","unstructured":"Ferrari, R., Guardigli, G., Mele, D., Percoco, G. F., Ceconi, C., & Curello, S. (2004). Oxidative stress during myocardial ischaemia and heart failure. Current Pharmaceutical Design, 10(14), 1699\u20131711.","journal-title":"Current Pharmaceutical Design"},{"issue":"4","key":"9462_CR99","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bcp.2005.05.036","volume":"71","author":"K Kovacs","year":"2006","unstructured":"Kovacs, K., Toth, A., Deres, P., Kalai, T., Hideg, K., Gallyas, F., Jr., et al. (2006). Critical role of PI3-kinase\/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion. Biochemical Pharmacology, 71(4), 441\u2013452.","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"9462_CR100","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yjmcc.2006.03.427","volume":"41","author":"A Palfi","year":"2006","unstructured":"Palfi, A., Toth, A., Hanto, K., Deres, P., Szabados, E., Szereday, Z., et al. (2006). PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C\/glycogen synthase kinase-3beta pathway. Journal of Molecular and Cellular Cardiology, 41(1), 149\u2013159.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"8","key":"9462_CR101","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.febslet.2006.02.056","volume":"580","author":"N Gurusamy","year":"2006","unstructured":"Gurusamy, N., Watanabe, K., Ma, M., Prakash, P., Hirabayashi, K., Zhang, S., et al. (2006). Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: Effect of losartan and tempol. FEBS Letters, 580(8), 1932\u20131940.","journal-title":"FEBS Letters"},{"key":"9462_CR102","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jcyt.2014.01.415","volume":"16","author":"RJ Henning","year":"2014","unstructured":"Henning, R. J., Sanberg, P., & Jimenez, E. (2014). Human cord blood stem cell paracrine factors activate the survival protein kinase Akt and inhibit death protein kinases JNK and p38 in injured cardiomyocytes. Cytotherapy, 16, 1158\u20131168. https:\/\/doi.org\/10.1016\/j.jcyt.2014.01.415 .","journal-title":"Cytotherapy"},{"key":"9462_CR103","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3727\/096368912X661427","volume":"22","author":"H Jin","year":"2013","unstructured":"Jin, H., Sanberg, P. R., & Henning, R. J. (2013). Human umbilical cord blood mononuclear cell-conditioned media inhibits hypoxic-induced apoptosis in human coronary artery endothelial cells and cardiac myocytes by activation of the survival protein Akt. Cell Transplantation, 22, 1637\u20131650. https:\/\/doi.org\/10.3727\/096368912X661427 .","journal-title":"Cell Transplantation"},{"issue":"4","key":"9462_CR104","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/01.CCM.0000206470.47721.8D","volume":"34","author":"FG Soriano","year":"2006","unstructured":"Soriano, F. G., Nogueira, A. C., Caldini, E. G., Lins, M. H., Teixeira, A. C., Cappi, S. B., et al. (2006). Potential role of poly(adenosine 5\u2032-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Critical Care Medicine, 34(4), 1073\u20131079.","journal-title":"Critical Care Medicine"},{"key":"9462_CR105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/9780470059593.ch7","volume":"280","author":"C Szab\u00f3","year":"2007","unstructured":"Szab\u00f3, C. (2007). Poly(ADP-ribose) polymerase activation and circulatory shock. Novartis Foundation Symposium, 280, 92\u2013103. (discussion 103-7, 160-4).","journal-title":"Novartis Foundation Symposium"},{"issue":"2","key":"9462_CR106","first-page":"369","volume":"17","author":"P Pacher","year":"2006","unstructured":"Pacher, P., Liaudet, L., Mabley, J. G., Czir\u00e1ki, A., Hask\u00f3, G., & Szab\u00f3, C. (2006). Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure. International Journal of Molecular Medicine, 17(2), 369\u2013375.","journal-title":"International Journal of Molecular Medicine"},{"issue":"15","key":"9462_CR107","first-page":"2775","volume":"127","author":"L Li","year":"2014","unstructured":"Li, L., Hu, B., Gong, S., Yu, Y., Dai, H., & Yan, J. (2014). Association of poly(ADP-ribose) polymerase activity in circulating mononuclear cells with myocardial dysfunction in patients with septic shock. Chinese Medical Journal (England), 127(15), 2775\u20132778.","journal-title":"Chinese Medical Journal (England)"},{"key":"9462_CR108","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318225c21e","author":"E Bartha","year":"2011","unstructured":"Bartha, E., Solti, I., Szabo, A., Olah, G., Magyar, K., Szabados, E., et al. (2011). Regulation of kinase cascade activation and heat shock protein expression by poly(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure. Journal of Cardiovascular Pharmacology. https:\/\/doi.org\/10.1097\/FJC.0b013e318225c21e .","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9462_CR109","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp144","author":"E Bartha","year":"2009","unstructured":"Bartha, E., Solti, I., Kereskai, L., Lantos, J., Plozer, E., Magyar, K., et al. (2009). PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats. Cardiovascular Research. https:\/\/doi.org\/10.1093\/cvr\/cvp144 .","journal-title":"Cardiovascular Research"},{"key":"9462_CR110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102148","author":"L Deres","year":"2014","unstructured":"Deres, L., Bartha, E., Palfi, A., Eros, K., Riba, A., Lantos, J., et al. (2014). PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1\/GSK-3\u03b2 and several PKC isoforms. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0102148 .","journal-title":"PLoS ONE"},{"issue":"14","key":"9462_CR111","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2741\/3244","volume":"1","author":"E Esposito","year":"2009","unstructured":"Esposito, E., & Cuzzocrea, S. (2009). Superoxide, NO, peroxynitrite and PARP in circulatory shock and inflammation. Frontiers in Bioscience (Landmark Edition), 1(14), 263\u2013296.","journal-title":"Frontiers in Bioscience (Landmark Edition)"},{"issue":"4","key":"9462_CR112","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2217\/fca-2016-0081","volume":"13","author":"RJ Henning","year":"2017","unstructured":"Henning, R. J., & Harbison, R. D. (2017). Cardio-oncology: Cardiovascular complications of cancer therapy. Future Cardiology, 13(4), 379\u2013396.","journal-title":"Future Cardiology"},{"key":"9462_CR113","first-page":"dju232","volume":"06","author":"N Shelburne","year":"2014","unstructured":"Shelburne, N., Adhikari, B., Brell, J., Davis, M., Desvigne-Nickens, P., Freedman, A., et al. (2014). Cancer treatment-related cardiotoxicity: Current state of knowledge and future research priorities. Journal of the National Cancer Institute, 06, dju232.","journal-title":"Journal of the National Cancer Institute"},{"key":"9462_CR114","unstructured":"Coyle, J. P. (2016). The influence of oxygen tension and glycolytic and citric acid cycle substrates in acrolein-induced cellular injury in the differentiated H9c2 cardiac cell model. A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy with a concentration in Toxicology and Risk Assessment. Department of Environmental and Occupational Health College of Public Health, University of South Florida."},{"key":"9462_CR115","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12012-016-9396-5","volume":"17","author":"RJ Henning","year":"2017","unstructured":"Henning, R. J., Johnson, G., Coyle, J., & Harbison, R. (2017). Acrolein can cause cardiovascular disease: A review. Cardiovascular Toxicology, 17, 227\u2013236.","journal-title":"Cardiovascular Toxicology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-018-9462-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-018-9462-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-018-9462-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T09:55:41Z","timestamp":1751709341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-018-9462-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":115,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["9462"],"URL":"https:\/\/doi.org\/10.1007\/s12012-018-9462-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,2]]},"assertion":[{"value":"2 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}